Radioligand Therapy for Prostate Cancer: What Patients & Care Partners Should Know

Dr. Alan Bryce (City of Hope) and Dr. Neeraj Agarwal (Dana-Farber Cancer Institute) discuss radioligand therapy for advanced prostate cancer.

Learn about:

• Radioligand therapy delivers radiation through an IV directly to prostate cancer cells.
• Once reserved for later disease states, radioligand therapy is now an option for patients with metastatic prostate cancer who have not received hormone therapy or whose cancer still responds to hormone therapy.
• What to expect during treatment, including the dosing schedule, common side effects, and simple precautions at home.

This video was produced with support from: